Antimicrobial Activity of the Secondary Metabolites Isolated from a South African Red Seaweed, Laurencia corymbosa

Author:

Fakee Jameel1,Bolton John J.2,Le Roes-Hill Marilize3ORCID,Durrell Kim A.3,Antunes Edith4ORCID,Beukes Denzil R.5ORCID

Affiliation:

1. Faculty of Pharmacy, Rhodes University, Makhanda 6140, South Africa

2. Department of Biological Sciences, University of Cape Town, Rondebosch 7701, South Africa

3. Applied Microbial and Health Biotechnology Institute, Cape Peninsula University of Technology, Bellville 7535, South Africa

4. Department of Chemistry, University of the Western Cape, Bellville 7535, South Africa

5. School of Pharmacy, University of the Western Cape, Bellville 7535, South Africa

Abstract

South Africa’s highly diverse marine biota includes several endemic marine red algae of the Laurencia genus. Cryptic species and morphological variability make the taxonomy of Laurencia plant challenging, and a record of the secondary metabolites isolated from South African Laurencia spp. can be used to assess their chemotaxonomic significance. In addition, the rapid development of resistance against antibiotics, coupled with the inherent ability of seaweeds to resist pathogenic infection, supported this first phycochemical investigation of Laurencia corymbosa J. Agardh. A new tricyclic keto-cuparane (7) and two new cuparanes (4, 5) were obtained alongside known acetogenins, halo-chamigranes, and additional cuparanes. These compounds were screened against Acinetobacter baumannii, Enterococcus faecalis, Escherichia coli, Staphylococcus aureus, and Candida albicans, with 4 exhibiting excellent activity against the Gram-negative A. baumanii (minimum inhibitory concentration (MIC) 1 μg/mL) strain.

Funder

National Research Foundation of South Africa

Publisher

MDPI AG

Subject

Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science

Reference38 articles.

1. Marine drugs: Biology, pipelines, current and future prospects for production;Papon;Biotechnol. Adv.,2022

2. NIH US National Library of Medicine (2023, February 04). ClinicalTrials.gov. 2000–2022, Available online: https://clinicaltrials.gov/.

3. NCI (2023, February 04). NCI Thesaurus, Available online: https://ncit.nci.nih.gov/.

4. ACDREVIEW (2023, February 04). Journal of Antibody-drug Conjugates. Available online: https://www.adcreview.com/.

5. Mayer, A. (2023, February 04). Marine Pharmacology. Available online: https://www.marinepharmacology.org.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3